semaglutide Archives -

Gilead and Novo plot next steps after trial data from NASH combo

https://pharmaphorum.com/news/gilead-and-novo-plot-next-steps-after-encouraging-data-from-nash-combo/

Towards a new understanding of cardiovascular risk in diabetes

https://pharmaphorum.com/r-d/views-analysis-r-d/towards-a-new-understanding-of-cardiovascular-risk-in-diabetes/

Novo’s new oral GLP-1 Rybelsus still has obstacles to overcome

https://pharmaphorum.com/news/novos-new-oral-glp-1-still-has-obstacles-to-overcome/

Gilead and Novo Nordisk collaborate for NASH trial

https://pharmaphorum.com/news/gilead-and-novo-nordisk-collaborate-for-nash-trial/

Novo’s oral semaglutide on target in phase 3 trial

https://pharmaphorum.com/news/novos-oral-semaglutide-target-phase-3-trial/

Novo’s diabetes pill beats injections in head-to-head trials

https://pharmaphorum.com/news/novo-nordisks-success-with-oral-diabetes-drug/

FDA experts back Novo Nordisk’s key diabetes drug

https://pharmaphorum.com/news/fda-experts-back-novo-nordisks-semaglutide/

No cardio protection indication for Novo’s semaglutide – yet

https://pharmaphorum.com/news/no-cardio-protection-label-novos-semaglutide-yet/

PureTech’s device could rival Saxenda in obesity market

https://pharmaphorum.com/news/puretech-aims-weight-loss-market-gelesis100/

Search